Basit öğe kaydını göster

dc.contributor.authorAktas, ES
dc.contributor.authorFicicioglu, S
dc.contributor.authorErsoy, L
dc.contributor.authorErturk, S
dc.date.accessioned2021-03-04T07:53:50Z
dc.date.available2021-03-04T07:53:50Z
dc.date.issued2003
dc.identifier.citationErturk S., Aktas E., Ersoy L., Ficicioglu S., "An HPLC method for the determination of atorvastatin and its impurities in bulk drug and tablets", JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, cilt.33, sa.5, ss.1017-1023, 2003
dc.identifier.issn0731-7085
dc.identifier.otherav_6077aa8c-2d45-4f67-954e-6ad405923101
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/67307
dc.identifier.urihttps://doi.org/10.1016/s0731-7085(03)00408-4
dc.description.abstractA simple high-performance liquid chromatographic (HPLC) method was developed for the analysis of atorvastatin (AT) and its impurities in bulk drug and tablets. This method has shown good resolution for AT, desfluoro-atorvastatin (DFAT), diastereomer-atorvastatin (DSAT), unknown impurities and formulation excipients of tablets. A gradient reverse-phase HPLC assay was used with UV detection. Some solvent systems prepared using methanol or acetonitrile and water or buffer systems with different pH values were tested. Capacity factors of related substances were calculated at all tested systems. Best resolution has been determined using a Luna C-18 column with acetonitrile-ammonium acetate buffer pH 4-tetrahydrofuran (THF) as mobile phase. Samples were eluted gradiently with the mobile phase at flow rate 1.0 ml min(-1) and detected at 248 nm. The proposed method was applied to the determination of impurities and were found to contain 0.057-0.081, 0.072-0.097, 0.608-0.664% of the DFAT, DSAT and total impurity, respectively. (C) 2003 Elsevier B.V. All rights reserved.
dc.language.isoeng
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectAnalitik Kimya
dc.subjectTemel Bilimler
dc.subjectSağlık Bilimleri
dc.subjectEczacılık
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectTemel Bilimler (SCI)
dc.subjectKimya
dc.subjectKİMYA, ANALİTİK
dc.titleAn HPLC method for the determination of atorvastatin and its impurities in bulk drug and tablets
dc.typeMakale
dc.relation.journalJOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
dc.contributor.department, ,
dc.identifier.volume33
dc.identifier.issue5
dc.identifier.startpage1017
dc.identifier.endpage1023
dc.contributor.firstauthorID169999


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster